Clearmind Medicine Inc. Adjustments For Decrease Increase In Trade Account Receivable
Clearmind Medicine Inc. (CMND) reported Adjustments For Decrease Increase In Trade Account Receivable of -$100.20 thousand for the 6-month period ending 2023-04-30, per its 6-K filed 2023-06-14.
Discontinued › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable · last filed 2023-06-14
- Clearmind Medicine Inc. adjustments for decrease increase in trade account receivable for the quarter ending 2023-01-31 was -257.59K CAD, a 781.08% decline year-over-year.
- Clearmind Medicine Inc. adjustments for decrease increase in trade account receivable for the quarter ending 2022-01-31 was 37.82K CAD.
CAD
| Period end | Adjustments For Decrease Increase In Trade Account Receivable 3 month | Adjustments For Decrease Increase In Trade Account Receivable 12 month |
|---|---|---|
| 2023-01-31 | -257.59K CAD 6-K · filed 2023-03-17 | |
| 2022-10-31 | 27.21K CAD 20-F · filed 2023-02-06 | |
| 2022-01-31 | 37.82K CAD 6-K · filed 2023-03-17 | |
| 2021-10-31 | -157.74K CAD 20-F · filed 2023-02-06 | |
| 2020-10-31 | -28.00 CAD 20-F · filed 2023-02-06 |
USD
| Period end | Adjustments For Decrease Increase In Trade Account Receivable 6 month |
|---|---|
| 2023-04-30 | -$100.20K 6-K · filed 2023-06-14 |
| 2022-04-30 | -$62.81K 6-K · filed 2023-06-14 |